Real world evidence to support payer/HTA decisions about highly innovative technologies in the EU—actions for stakeholders

International Journal of Technology Assessment in Health Care

3 September 2020 - There are divergent views on the potential of real world data to inform decisions made by regulators, health technology assessment bodies, payers, clinicians, and patients. 

This RWE4Decisions initiative explored the particularly challenging setting of highly innovative technologies, which require payers/HTAs to make decisions on a small evidence base with major uncertainties. 

The aim was to go beyond strategic intent to consider actions that each stakeholder could take to improve use of real world data in this setting.

Read International Journal of Technology Assessment in Health Care article

Michael Wonder

Posted by:

Michael Wonder